2 active not recruiting. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Recurrent Endometrial Adenocarcinoma: new trials by email Literature Review of Recurrent Endometrial Adenocarcinoma trials Research Report on Recurrent Endometrial Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer Carboplatin, Computed Tomography, Paclitaxel - Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 813 | 2019-08-22 | 2026-10-21 |
| VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer Biopsy, Computed Tomography, Fluorine F 18 Tetrafluoroborate - Metastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma | Phase 1 | Active not recruiting | Mayo Clinic | 34 | 2017-09-15 | 2026-07-21 |
Endometrial Neoplasms (2) · Carcinosarcoma (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Uterine Diseases (2) · Uterine Neoplasms (2) · Neoplasms by Histologic Type (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Connective and Soft Tissue (1) · Sarcoma (1)
Biopsy (1) · Carboplatin (1) · Magnetic Resonance Spectroscopy (1) · Paclitaxel (1) · Radionuclide Generators (1) · Sodium Pertechnetate Tc 99m (1) · Specimen Handling (1) · Taxes (1) · pembrolizumab (1) · ruxolitinib (1) · sodium-iodide symporter (1)
Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (2) · Canada (1) · Japan (1) · Puerto Rico (1) · South Korea (1)
Jamie N. Bakkum-Gamez, M.D. (1) · Ramez N Eskander (1)
PMID 36972022, PMID 37411031, PMID 38431043, PMID 40044930
R01CA207240 (1), U10CA180868 (1)